Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).
about
Heparin-induced thrombocytopenia and cardiovascular patients: recognition and treatment.Review: recent advances in argatroban-warfarin transition in patients with heparin-induced thrombocytopenia.The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT.Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition.Minimal Prolongation of Prothrombin Time with Extended Exposure to Argatroban.How we manage patients with heparin induced thrombocytopenia.Implementation of a Simplistic Bivalirudin-Warfarin Transition Protocol Is Associated With Improved Achievement of INR Values Within the Therapeutic Range.Use of the chromogenic factor X assay in patients transitioning from argatroban to warfarin therapy.Development of a Predictive Nomogram for the Change in PT/INR Upon Discontinuation of Bivalirudin as a Bridge to Warfarin.Superficial vein thrombosis.Management of pulmonary embolism: state of the art treatment and emerging research.
P2860
Q33370473-B3149352-E0E9-4099-8D7A-E197984ADDCDQ33382275-4EE725BF-7FC2-44EC-830D-3A75D1244363Q33385970-276C2855-3B26-40E2-9323-A6813C984D00Q33386621-304A529A-A6D9-4C6D-99BB-BB448FFE9E40Q33399580-0A5E0478-64F0-4CBC-A32D-AC46CE677737Q33403703-6028E67D-7F1E-4CE5-A6B6-2BBBB3E289CBQ33424161-3ACA6B14-9AD8-45E4-AC53-44EE14461622Q33431626-A67E2FF0-1B37-4A0A-B4ED-3EEB85A7B458Q33434297-D9E9B59D-C6AA-4DE8-A626-CB1777F4838CQ38003322-84627F43-2357-4DDD-86EE-E7E01EA35AA5Q39905565-9E739E0A-3B93-4BCE-BB9D-19715F61F3C0Q43905870-CD0CCBC0-073F-40D8-BBF8-BC025DEC3454Q44304204-3E83D0B4-9969-4C20-BB02-3C22F87EA091
P2860
Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Transitioning from argatroban ...... tional normalized ratio (INR).
@ast
Transitioning from argatroban ...... tional normalized ratio (INR).
@en
type
label
Transitioning from argatroban ...... tional normalized ratio (INR).
@ast
Transitioning from argatroban ...... tional normalized ratio (INR).
@en
prefLabel
Transitioning from argatroban ...... tional normalized ratio (INR).
@ast
Transitioning from argatroban ...... tional normalized ratio (INR).
@en
P2860
P1476
Transitioning from argatroban ...... tional normalized ratio (INR).
@en
P2093
John R Bartholomew
Marcie J Hursting
P2860
P2888
P304
P356
10.1007/S11239-005-1849-9
P577
2005-06-01T00:00:00Z